Show simple item record

dc.contributor.authorTodt, Daniel
dc.contributor.authorSchlevogt, Bernhard
dc.contributor.authorDeterding, Katja
dc.contributor.authorGrundhoff, Adam
dc.contributor.authorManns, Michael P
dc.contributor.authorWedemeyer, Heiner
dc.contributor.authorFischer, Nicole
dc.contributor.authorCornberg, Markus
dc.contributor.authorSteinmann, Eike
dc.date.accessioned2017-03-07T09:40:41Z
dc.date.available2017-03-07T09:40:41Z
dc.date.issued2017-01-18
dc.identifier.citationSuccessful retreatment of a patient with chronic hepatitis C genotype 2k/1b virus with ombitasvir/paritaprevir/ritonavir plus dasabuvir. 2017 J. Antimicrob. Chemother.en
dc.identifier.issn1460-2091
dc.identifier.pmid28100444
dc.identifier.doi10.1093/jac/dkw572
dc.identifier.urihttp://hdl.handle.net/10033/620850
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleSuccessful retreatment of a patient with chronic hepatitis C genotype 2k/1b virus with ombitasvir/paritaprevir/ritonavir plus dasabuvir.en
dc.typeArticleen
dc.contributor.departmentTwincore Centre of Experimental and Clinical Infection Research; a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover 30625, Germany.en
dc.identifier.journalThe Journal of antimicrobial chemotherapyen
refterms.dateFOA2018-01-18T00:00:00Z


Files in this item

Thumbnail
Name:
Todt et al.pdf
Size:
702.7Kb
Format:
PDF
Description:
original manuscript

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-sa/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/